For the quarter ending 2025-09-30, CPIX had -$890,536 decrease in cash & cash equivalents over the period. $163,392 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -1,949,046 | 512,977 |
| Depreciation and amortization expense | 1,037,804 | 2,065,502 |
| Reduction in the carrying amount of right-of-use assets | 285,184 | 570,369 |
| Share-based compensation | 81,262 | 154,898 |
| Increase (decrease) in non-cash contingent consideration | 9,651 | 83,578 |
| Increase in cash surrender value of life insurance policies over premiums paid | 91,460 | 40,507 |
| Noncash interest expense | 5,362 | 10,723 |
| Loss on disposal of assets | 0 | - |
| Life insurance proceeds | 0 | - |
| Accounts receivable | 113,691 | -1,384,555 |
| Inventories, net | -630,409 | -1,818,196 |
| Other current assets and other assets | -178,936 | -640,023 |
| Operating lease liabilities | -221,675 | -440,442 |
| Accounts payable and other current liabilities | 684,224 | -2,018,925 |
| Other long-term liabilities | -349,780 | 1,371 |
| Net cash provided by (used in) operating activities | 187,180 | 4,742,318 |
| Additions to property and equipment | 23,788 | 74,116 |
| Life insurance policy proceeds received | 0 | - |
| Increase in cash surrender value of life insurance policies | 47,000 | - |
| Net investment in manufacturing | 611,600 | 836,095 |
| Additions to intangible assets | 8,449 | 32,111 |
| Net cash (used in) provided by investing activities | -690,837 | -942,322 |
| Proceeds from atm offering, net | 0 | -5,266,334 |
| Borrowings on line of credit | 0 | 0 |
| Payments on line of credit | 0 | 10,035,437 |
| Cash settlement of contingent consideration | 376,440 | 654,757 |
| Payments made in connection with repurchase of common shares | 10,439 | 253,039 |
| Net cash (used in) provided by financing activities | -386,879 | -5,676,899 |
| Net decrease in cash and cash equivalents | -890,536 | -1,876,903 |
| Cash and cash equivalents at beginning of period | 17,964,184 | - |
| Cash and cash equivalents at end of period | 15,196,745 | - |
CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC (CPIX)